Imagin Medical Secures New $3 Million Convertible Note Financing
Rapha Capital BioVentures Fund I, LP (RCBVFI) leads new convertible note financing.Kevin Slawin, M.D., a leading urooncologist and manager of...
News
Cellectis Announces Participation in Five Investor Conferences
NEW YORK, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing...
Streamline Health® To Report Second Quarter 2021 Financial Performance and Provide Corporate Update
ATLANTA, GA, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program...
Premier Health Reports Strong 3ʳᵈ Quarter Results
MONTRÉAL, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech...
Sight Sciences to Participate in the Morgan Stanley Global Healthcare Conference
MENLO PARK, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused...
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
Shares of Aadi to commence trading on the Nasdaq Capital Market on August 27, 2021 under ticker symbol “AADI”Concurrent $155...
Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp.
Kathleen Sebelius Chair of Humacyte's Board of Directors Dr. Laura Niklason Founder, President & CEO of Humacyte Rajiv Shukla CEO...
Rapid Micro Biosystems Reports Second Quarter 2021 Financial Results and Provides Business Update and Full Year 2021 Outlook
Reports second quarter 2021 commercial revenue of $5.7 million, representing 135% year-over-year growth Issues full-year 2021 outlook for commercial revenue...
Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC Programs
Innovent will provide proprietary antibodies for selected tumor targets and Bolt will provide its proprietary Boltbody™ technology to create new...
Clover Health to Present at the 2021 Wells Fargo Virtual Healthcare Conference on September 9, 2021
NASHVILLE, Tenn., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV), a technology company committed to improving...
Aclaris Therapeutics to Participate in Upcoming Investor Conferences
WAYNE, Pa., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing...
Inari Medical to Present at Upcoming Investor Conferences
IRVINE, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused...
Erasca Reports Second Quarter 2021 Financial Results and Business Updates
Successfully closed $345 million upsized IPO in July 2021 On track to initiate multiple HERKULES Phase 1b/2 trials in 2021...
AVITA Medical Reports Fourth Quarter and Fiscal Year 2021 Financial Results
VALENCIA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (Company), a regenerative medicine company that...
Mountain Valley MD Holdings to Graduate to OTCQX Best Market, Updates Broader Up-Listing Strategy
TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA: 20MP)...
Kane Biotech Announces Second Quarter 2021 Financial Results
Strong pipeline of opportunities across all three strategic pillarsWINNIPEG, Manitoba, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-...
Sorrento Exercises Exclusive Option Agreement With Texas A&M University for MPRO Inhibitors Against Sars-Cov-2 and all Variants of Concern
Exclusive license for MPro inhibitors supports rapidly growing small molecule development portfolio for combating COVID-19.Lead compound, MPI8, exhibited potent in...
UPDATE – SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021
BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report...
Sorrento Reports Promising Results With mRNA Vaccine For COVID-19 Delivered With The MuVaxx Lymphatic Drug Delivery Device
Sorrento’s mRNA vaccine (“STI-mRNA”) delivered with the MuVaxx™ Lymphatic Drug Delivery Device (“MuVaxx”), at 1/10th of the dose vs an...
MDxHealth Reports Half Year 2021 Results
NEWS RELEASE - REGULATED INFORMATION26 AUGUST 2021, 18:00 CET MDxHealth Reports Half Year 2021 Results Conference call with Q&A today...
